Philadelphia Biotech Startup Context Therapeutics Names a New CFO, Effective Immediately Post author:Sam Post published:November 15, 2017 Post category:BioPharma The company is strengthening its team as it transitions to a clinical development stage company. Source: BioSpace You Might Also Like Blueprint Medicines To Report Second Quarter 2017 Financial Results On Wednesday, August 2, 2017 July 25, 2017 Bay Area's Coherus Dealt Another Blow as Daiichi Sankyo Discontinues Work on RA Drug July 4, 2017 With a Collaboration Deal in Place with Merck, Cue Biopharma Plans $60 Million IPO December 18, 2017
Blueprint Medicines To Report Second Quarter 2017 Financial Results On Wednesday, August 2, 2017 July 25, 2017